Clinical Trial Update: A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea

View source ↗

Summary

This completed study in Korea quantified how many rheumatoid arthritis patients meet the criteria to receive anti-TNF therapy in a general hospital setting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Rheumatoid Arthritis | Status: COMPLETED